Evidence map›Paper›PMID 27803980›Full record

ArticleEuropean journal of orthopaedic surgery & traumatology : orthopedie traumatologie2017

Combining a novel leucocyte-platelet-concentrated membrane and an injectable collagen scaffold in a single-step AMIC procedure to treat chondral lesions of the knee: a preliminary retrospective study.

Corrado D'Antimo, Francesco Biggi, Alessio Borean, Stefano Di Fabio, Ivan Pirola

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of orthopaedic surgery & traumatology : orthopedie traumatologie, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Nanotechnology: the scope and potential applications in orthopedic surgery.European journal of orthopaedic surgery & traumatology : orthopedie traumatologie · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Corrado D'AntimoOrthopaedics and Traumatology Department, San Martino Hospital, Belluno, Italy. corrado.dantimo@virgilio.it.ORCID http://orcid.org/0000-0002-4203-9443
Francesco BiggiOrthopaedics and Traumatology Department, San Martino Hospital, Belluno, Italy.
Alessio BoreanImmunohematology and Transfusion Medicine Department, San Martino Hospital, Belluno, Italy.
Stefano Di FabioOrthopaedics and Traumatology Department, San Martino Hospital, Belluno, Italy.
Ivan PirolaImmunohematology and Transfusion Medicine Department, San Martino Hospital, Belluno, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDifferent surgical approaches are currently available to treat knee chondral defects. Microfracture is the most commonly applied, but it often leads to a mechanically inferior fibrocartilaginous tissue. To overcome this shortcoming, the Autologous, Matrix-Induced Chondrogenesis (AMIC) technique has been proposed. To further enhance the outcome of AMIC, the addition of haemoderivatives containing growth factors that stimulate cartilage healing has emerged as a new treatment method. Recently, a novel leucocyte-platelet-concentrated membrane (CLP-MB), highly enriched in platelets, monocytes/macrophages, fibrinogen, CD34

aimsThis preliminary study is aimed to evaluate the short-term safety and efficacy of the use of the CLP-MB membrane and injectable collagen scaffold when combined in single-step AMIC procedures for the treatment of knee chondral lesions.

methodsMedical records of patients who underwent an AMIC procedure with the CLP-MB membrane combined with Cartifill were reviewed retrospectively. Follow-up assessments were conducted at 6 and 12 months after surgery. Clinical function was assessed on the basis of the International Knee Documentation Committee (IKDC) score. Pain was evaluated using the visual analogue scale (VAS).

resultsTwenty-five patients were identified as meeting the inclusion criteria. Mean IKDC and VAS scores significantly improved during the follow-up time. The postoperative course was uneventful.

conclusionsAMIC combined with the CLP-MB membrane, and Cartifill seems to be a promising approach to treat knee chondral defects.

Indexed as

Membranes, ArtificialTissue ScaffoldsAC133 AntigenAdolescentAdultAntigens, CD34Blood PlateletsCartilage, ArticularChondrogenesisCollagenFemaleFibrinogenHumansInjections, Intra-ArticularKnee JointMacrophagesAC133 AntigenAntigens, CD34CollagenFibrinogenKDR protein, humanMembranes, ArtificialVascular Endothelial Growth Factor Receptor-2AMIC procedureCartifillHaemoderivativesKnee chondral defectsLeucocyte–platelet-concentrated membrane

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.